Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older.
Outcomes and tolerability of chemoradiation therapy for pancreatic cancer patients aged 75 years or older. Int J Radiat Oncol Biol Phys. 2010 Jul 15; 77(4):1171-7.
View in:
PubMed
subject areas
Age Factors
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Combined Modality Therapy
Comorbidity
Failure to Thrive
Female
Humans
Male
Nausea
Neoplasm Staging
Pain
Pancreatic Neoplasms
Radiotherapy Dosage
Severity of Illness Index
Statistics, Nonparametric
Survival Analysis
Treatment Outcome
Vomiting
authors with profiles
David Tomoaki Miyamoto, M.D., Ph.D.
Carlos F. Fernandez-Del Castillo, M.D.
David P. Ryan, M.D.
Theodore Sunki Hong, M.D.
Harvey Jay Mamon, M.D., Ph.D.
Lawrence Scott Blaszkowsky, M.D.